NEUROCRINE BIOSCIENCES, INC. Quotes Neurocrine Biosciences, Inc. Deutsche Boerse AG
Equities
NB3
US64125C1099
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.6 EUR | -0.37% |
|
-1.93% | +2.36% |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 04/06/2024 | 05/06/2024 | 06/06/2024 | 07/06/2024 | |
|---|---|---|---|---|
| Last | 127.7 € | 122.35 € | 122.1 € | 121.65 € |
| Volume | 0 | 0 | 15 | 0 |
| Change | +2.24% | -4.19% | -0.20% | -0.37% |
| Opening | 127.70 | 122.35 | 122.10 | 121.65 |
| High | 127.70 | 122.35 | 122.10 | 121.65 |
| Low | 127.70 | 122.35 | 122.10 | 121.65 |
Performance
| 1 day | -0.37% | ||
| 1 week | -1.93% | ||
| Current month | -1.93% | ||
| 1 month | -7.17% | ||
| 3 months | +0.95% | ||
| 6 months | +10.34% | ||
| Current year | +2.36% | ||
| 1 year | +37.27% | ||
| 3 years | +57.86% | ||
| 5 years | +70.90% | ||
| 10 years | +1,030.79% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
43
Daily volume ratio
0.00
Avg. Volume 20 sessions
5 230.95
Avg. Volume 20 sessions USD
5 649.43
Record volume 1
16 570
Record volume 2
16 562
Record volume 3
16 219
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
13 583 006 528
Capitalization (USD)
13 583 006 528
Net sales (USD)
1 887 100 000
Number of employees
1 448
Sales / Employee (USD)
1 303 246
Free-Float
98.2 %
Free-Float capitalization (EUR)
14 405 016 773
Free-Float capitalization (USD)
13 337 979 561
Average Daily Capital Traded
0%
Highs and lows
1 week
121.65
127.70
1 month
121.65135.75
Current year
118.25136.00
1 year
83.96136.00
3 years
63.54136.00
5 years
63.54136.00
10 years
9.35136.00
Indicators
Moving average 5 days
124.22
Moving average 20 days
127.47
Moving average 50 days
127.79
Moving average 100 days
126.83
Price spread / (MMA5)
+2.11%
Price spread / (MMA20)
+4.79%
Price spread / (MMA50)
+5.05%
Price spread / (MMA100)
+4.26%
STIM
RSI 9 days
35.52
RSI 14 days
39.51
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.37% | -1.93% | +2.36% | +37.27% | 13.58B | ||
| -0.51% | +6.08% | +18.72% | +48.79% | 125B | ||
| +0.22% | +2.33% | +14.19% | +35.79% | 108B | ||
| -1.44% | -0.26% | -4.93% | -8.29% | 24.21B | ||
| +0.51% | +4.08% | +3.23% | -3.95% | 22.78B | ||
| -0.54% | -0.36% | -10.44% | -28.25% | 17.96B | ||
| -0.45% | +0.66% | -41.74% | -33.01% | 16.43B | ||
| -0.79% | +5.05% | -13.31% | -30.32% | 16.37B | ||
| +5.01% | -5.04% | +27.89% | -3.58% | 11.66B | ||
| -0.56% | +3.27% | +83.45% | +187.41% | 9.17B | ||
| -2.13% | +13.90% | -24.26% | -33.18% | 8.31B | ||
| -0.96% | +1.53% | +8.91% | +51.74% | 7.87B | ||
| -2.12% | +1.00% | +13.01% | +38.48% | 7.72B | ||
| -0.60% | -1.77% | -5.61% | +22.76% | 7.29B | ||
| -1.15% | +14.81% | +37.58% | +46.46% | 6.47B | ||
| -1.35% | +0.88% | -8.80% | +13.54% | 6.37B | ||
| Average | -0.45% | +3.09% | +6.26% | +21.35% | ||
| Weighted average by Cap. | -0.26% | +3.50% | +9.70% | +27.58% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +2.36% | ||
| 2023 | +6.17% | ||
| 2022 | +51.52% | ||
| 2021 | -2.61% | ||
| 2020 | -22.77% | ||
| 2019 | +61.25% | ||
| 2018 | -3.11% | ||
| 2017 | +75.26% | ||
| 2016 | -29.23% | ||
| 2015 | +177.23% | ||
| 2014 | +171.25% | ||
| 2013 | +20.31% | ||
| 2012 | -14.85% | ||
| 2011 | +13.00% | ||
| 2010 | +191.10% | ||
| 2009 | -16.67% | ||
| 2008 | -20.00% | ||
| 2007 | -61.73% | ||
| 2006 | -85.14% | ||
| 2005 | +46.53% | ||
| 2004 | -17.88% | ||
| 2003 | -2.58% | ||
| 2002 | -24.11% | ||
| 2001 | +56.88% | ||
| 2000 | +23.93% |
- Stock Market
- Equities
- NBIX Stock
- NB3 Stock
- Quotes Neurocrine Biosciences, Inc.